Abstract:Pancreatic stellate cells (PSCs) produce the stromal reaction in pancreatic cancer (PC), but their role in cancer progression has not been fully elucidated. Aims: To assess the influence of PSCs on PC growth using i) an orthotopic model of pancreatic cancer and ii) in vitro studies with cultured human PSCs and MiaPaCa2 (a human PC cell line). Methods: I) In vivo model: Athymic mice received an intrapancreatic injection of one of the following - saline (S), human PSCs (P), MiaPaCa2 cells (M), or human PSCs + MiaPaCa2 (1:1; P+M). After 7 weeks, mice were killed and tumor size and tumor spread assessed. Tumor histology was assessed with H&E, cytokeratin and α smooth muscle actin (αSMA) staining. II) In vitro studies: Effect of PSC secretions (from 3 separate human PSC preparations) on (a) PC cell proliferation - assessed by incorporation of 3H-thymidine into DNA of MiaPaCa2 cells incubated with PSC secretions for 24, 48 and 72h; (b) PC cell apoptosis - TUNEL staining used to assess basal and H2O2-stimulated MiaPaCa2 cell apoptosis, in the presence and absence of PSC secretions. Results: I) Orthotopic model: Mice injected with PSCs+MiaPaCa2 exhibited increased tumor size (Fig 1) and local and distant spread (Fig 2) compared to mice receiving MiaPaCa2 cells alone. No tumors were found in mice injected with PSCs alone. Morphometry of cytokeratin stained sections showed significantly higher epithelial cell numbers in the P+M group tumors compared to those in group M. αSMA staining revealed activated PSCs in fibrotic bands in P+M tumors with negligible staining in the other 3 groups. II) In vitro studies: (a) MiaPaCa2 proliferation was increased upon exposure to PSC secretions [24h - 217.4 ± 29.5*, 48h - 195.5±15.8*, 72h - 245.6±44.5* % of control; *p < 0.005]. (b) MiaPaCa2 apoptosis - Both basal and H2O2 stimulated apoptosis of MiaPaCa2 cells was significantly inhibited by PSC secretions. [Data as fold change: basal apoptosis 1; PSC secretions 0.45±0.05*, H2O2 16.39± 2.34**; H2O2+PSC secretions 3.59±0.81*; *p < 0.01].FIGURE 1: Primary tumour size. *p > 0.04: n = 5 mice/group.FIGURE 2: Local and distant spread. *p > 0.055: n = 5 mice/group.Conclusions: i) Pancreatic tumor growth and metastasis are significantly increased in mice receiving PSCs+MiaPaCa2 compared to those receiving MiaPaCa2 alone. The increase in tumor size is due to increased tumor cell number and not merely to fibrosis. ii) PSC secretions induce proliferation and inhibit apoptosis of PC cells. Implications: PSCs establish an environment that promotes tumor progression by stimulating proliferation and reducing apoptosis of pancreatic cancer cells.

Paracrine HGF Promotes EMT and Mediates the Effects of PSC on Chemoresistance by Activating C-Met/pi3k/akt Signaling in Pancreatic Cancer in Vitro.

HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis

EFFECT OF PARACRINE HEPATOCYTE GROWTH FACTOR IN PANCREATIC STELLATE CELLS ON CHEMOTHERAPY RESISTANCE IN PANCREATIC CANCER

Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α

Hepatocyte Growth Factor Inhibition: a Novel Therapeutic Approach in Pancreatic Cancer.

Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy

Pancreatic Stellate Cells Increase Pancreatic Cancer Cells Invasion Through the Hepatocyte Growth Factor /C-Met/survivin Regulated by P53/P21

Targeting the HGF/c-MET Pathway: Stromal Remodelling in Pancreatic Cancer.

Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor /c-Met/survivin regulated by P53/P21.

Hypoxia Activated HGF Expression in Pancreatic Stellate Cells Confers Resistance of Pancreatic Cancer Cells to EGFR Inhibition

HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer

Targeting HGF/c-MET Axis in Pancreatic Cancer

EFFECT OF PANCREATIC STELLATE CELL ON INVASION AND METASTASIS OF PANCREATIC CANCER CELLS VIA THE HGF/C-MET/SURVIVIN SIGNALING PATHWAY

Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis

Pancreatic Stellate Cells Facilitate Pancreatic Cancer Cell Viability and Invasion.

The Critical Roles of Activated Stellate Cells-Mediated Paracrine Signaling, Metabolism and Onco-Immunology in Pancreatic Ductal Adenocarcinoma

Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway.

CXCL5 knockdown attenuated gemcitabine resistance of pancreatic cancer through regulation of cancer cells and tumour stroma.

The Crosstalk Analysis between mPSCs and Panc1 Cells Identifies CCN1 as a Positive Regulator of Gemcitabine Sensitivity in Pancreatic Cancer Cells

Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis.

PANCREATIC STELLATE CELLS STIMULATE PANCREATIC CANCER GROWTH AND METASTASIS